Posted by Michael Wonder on 05 Aug 2015
[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \ \T \h \e \space \C \a \n \a \d \i \a \n \space \D \r \u \g \space \E \x \p \e \r \t \space \C \o \m \m \i \t \t \e \e \space \( \C \D \E \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \a \t \space \e \p \l \e \r \e \n \o \n \e \space \n \o \t \space \b \e \space \l \i \s \t \e \d \space \a \t \space \t \h \e \space \s \u \b \m \i \t \t \e \d \space \p \r \i \c \e " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
As part of its 25th anniversary celebrations, CADTH has launched a special lecture series on health technology assessment (HTA) in Canada.
CADTH ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
In its draft guidance, NICE says nalmefene should be available as an option for those who regularly drink high amounts of ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
5 December 2013 - Enzalutamide (Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \4 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \N \I \C \E \, \space \t \h \e \space \h \e \a \l \t \h \c \a \r \e \space \g \u \i \d \a \n \c \e \space \b \o \d \y \, \space \h \a \s \space \i \s \s \u \e \d \space \n \e \w \ \d \r \a \f \t \ \g \u \i \d \a \n \c \e \space \n \o \t \space \r \e \c \o \m \m \e \n \d \i \n \g \ \r \a \d \i \u \m \space \R \a \space \2 \2 \3 \space \d \i \c \h \l \o \r \i \d \e \ \X \o \f \i \g \o \, \space \B \a \y \e \r \) \, \space \f \o \r \space \t \r \e \a \t \i \n \g \space \a \d \u \l \t \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Patients with a specific type of bone marrow disorder in England and Wales will be disappointed by news that cost ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The man in charge of a special NHS fund for cancer medicines in England has said there will need to ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Many will have seen the recent news that the first and only targeted chemotherapy drug for secondary breast cancer has ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\4 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \ \P \H \A \R \M \A \C \space \i \s \space \s \e \e \k \i \n \g \space \f \e \e \d \b \a \c \k \space \o \n \space \a \space \p \r \o \p \o \s \a \l \space \t \o \space \a \m \e \n \d \space \t \h \e \space \l \i \s \t \i \n \g \space \o \f \space \t \w \o \space \t \u \m \o \u \r \space \n \e \c \r \o \s \i \s \space \f \a \c \t \o \r \space \i \n \h \i \b \i \t \o \r \s \, " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \ \B \e \l \o \w \space \i \s \space \a \space \l \i \s \t \space \o \f \space \f \o \r \t \h \c \o \m \i \n \g \space \s \u \b \m \i \s \s \i \o \n \s \space \t \h \a \t \space \h \a \v \e \space \r \e \c \e \n \t \l \y \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \t \h \e \space \S \M \C \' \s \space \w \o \r \k \ \p \r \o \g \r \a \m \m \e \. " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
An efficiency drive in the health department will save more than one billion dollars, the federal government says. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The National Institute for Health and Care Excellence has spoken out against renewed criticism of the way members of its ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The July 2014 issue of the New Zealand Schedule of Pharmaceutical Benefits is now in effect. There are no listings ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Cost regulators for National Health Service treatments in Scotland have approved five new medicines that will potentially benefit more than ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The presentations from the ISPOR Predicting Future Evidence Workshop in April 2015 are now available on the ISPOR-Australian Chapter website. ...
Read more →